Spots Global Cancer Trial Database for antioxidant
Every month we try and update this database with for antioxidant cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma. | NCT03540407 | Cervical Carcin... Cervical Carcin... Cervical Carcin... Endometrial Ade... Endometrial Ade... Endometrial Ade... | Oncoxin-Viusid® Placebo | 18 Years - 80 Years | Catalysis SL | |
Evaluation of Effects of Silymarin on Cisplatin Induced Nephrotoxicity in Upper Gastrointestinal Adenocarcinoma | NCT01829178 | Upper GI Cancer Cisplatin Adver... | Silymarin Placebo chemotherapy | 18 Years - 70 Years | Tehran University of Medical Sciences | |
Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal | NCT03584308 | Papilloma Viral... Papillomavirus ... Esophageal Vira... Esophageal Verr... | Viusid® Glizigen® Viusid Placebo Glizigen Placeb... | 18 Years - 65 Years | Catalysis SL | |
Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients | NCT00169845 | Neoplasms | Alpha-Tocophero... Placebo | 18 Years - | Laval University | |
Oncoxin® and Quality of Life in Cancer Patients | NCT03550482 | Gastric Cancer ... Non-small Cell ... Non-small Cell ... Gastric Cancer ... | ONCOXIN® | 50 Years - 70 Years | Catalysis SL | |
Dietary Intervention With Phytochemicals and Polyunsaturated Fatty Acids in Prostate Cancer Patients | NCT00433797 | Prostate Cancer | Prostate cancer... | - | University of Oslo | |
Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma | NCT03717298 | Adenocarcinoma ... Pancreatic Canc... Advanced Cancer Digestive Syste... Pancreatic Neop... Endocrine Gland... Digestive Syste... Endocrine Syste... Pancreatic Dise... | Ocoxin-Viusid® | 18 Years - | Catalysis SL | |
Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas. | NCT04175301 | Malignant Gliom... | Hydrogen Placebo oral ta... | 18 Years - | Stony Brook University | |
Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma | NCT03717298 | Adenocarcinoma ... Pancreatic Canc... Advanced Cancer Digestive Syste... Pancreatic Neop... Endocrine Gland... Digestive Syste... Endocrine Syste... Pancreatic Dise... | Ocoxin-Viusid® | 18 Years - | Catalysis SL | |
Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas. | NCT04175301 | Malignant Gliom... | Hydrogen Placebo oral ta... | 18 Years - | Stony Brook University | |
Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity. | NCT04291209 | Ototoxic Hearin... | N-Acetyl Cystei... | 18 Years - | Sunnybrook Health Sciences Centre | |
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma | NCT03559543 | Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Rectal Diseases Colonic Disease... Intestinal Dise... Gastrointestina... Digestive Syste... | Ocoxin-Viusid | 18 Years - | Catalysis SL | |
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma | NCT03559543 | Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Rectal Diseases Colonic Disease... Intestinal Dise... Gastrointestina... Digestive Syste... | Ocoxin-Viusid | 18 Years - | Catalysis SL | |
Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas. | NCT04175301 | Malignant Gliom... | Hydrogen Placebo oral ta... | 18 Years - | Stony Brook University |